← Browse by Condition
Medical Condition

bone lesion

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for bone lesion sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Top Sponsors
Nanjing First Hospital, Nanjing Medical University 1 trial
Central Hospital, Nancy, France 1 trial
Salzburger Landeskliniken 1 trial
NCT06249906
Recruiting

Efficacy of Bioceramic Materials for Bone Defects Repair

Enrollment
10 pts
Location
China
Sponsor
Nanjing First Hospital, Nanjin...
View Trial →
NCT05934994
Recruiting

Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions

Enrollment
68 pts
Location
France
Sponsor
Central Hospital, Nancy, Franc...
View Trial →
NCT06754137
Recruiting

Assessing AI-Supported Fracture Detection in Emergency Care Units

Enrollment
4,800 pts
Location
Austria, Germany
Sponsor
Salzburger Landeskliniken
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology